The Pharma Legal Handbook: Russia

Russia is one of the world's largest pharmaceutical markets and has a distinctive regulatory environment that combines national registration requirements administered by Roszdravnadzor with a complex pricing and reimbursement system tied to the essential medicines list (ONLS). The market has undergone significant change, with localisation requirements under the Pharma 2030 strategy reshaping commercial arrangements.

Russia's pricing system for essential medicines involves price registration with the Federal Antimonopoly Service, with reference to prices in a defined set of comparator countries. Understanding how the essential medicines list is managed, how price revisions are handled, and what the implications of localisation requirements are requires specialist knowledge.

The Pharma Legal Handbook: Russia provides comprehensive guidance on pharmaceutical regulation in Russia, covering Roszdravnadzor product registration, pricing and essential medicines list management, clinical trial requirements, pharmacovigilance obligations, manufacturing and localisation requirements, marketing rules, and intellectual property protection.